Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19.

Mu, Xiuying; Liu, Kai; Li, Huajie; Wang, Fu-Sheng; Xu, Ruonan

Mu, Xiuying; Liu, Kai; Li, Huajie; Wang, Fu-Sheng; Xu, Ruonan.

Mu X; Peking University 302 Clinical Medical School, Beijing, China.
Liu K; Peking University 302 Clinical Medical School, Beijing, China.
Li H; Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
Wang FS; Peking University 302 Clinical Medical School, Beijing, China.
Xu R; Peking University 302 Clinical Medical School, Beijing, China. fswang302@163.com.

Cell Mol Immunol ; 18(8): 2057-2058, 2021 08.

Article in English | MEDLINE | ID: covidwho-1317803

Subject(s)

COVID-19 Drug Treatment; Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use; Immunologic Factors/therapeutic use; SARS-CoV-2/pathogenicity; Sepsis/drug therapy; Animals; COVID-19/immunology; COVID-19/virology; Granulocyte-Macrophage Colony-Stimulating Factor/adverse effects; Granulocyte-Macrophage Colony-Stimulating Factor/antagonists & inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor/metabolism; Host-Pathogen Interactions; Humans; Immunologic Factors/adverse effects; Recombinant Proteins/therapeutic use; SARS-CoV-2/immunology; Sepsis/immunology; Sepsis/virology; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / Sepsis / SARS-CoV-2 / COVID-19 Drug Treatment / Immunologic Factors Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Cell Mol Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: S41423-021-00719-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google